Anish Nag - researchr alias

researchr

You are not signed in
Sign in
Sign up

Viewing Publication 1 - 5 from 5

2024

A top-down approach for studying the in-silico effect of the novel phytocompound tribulusamide B on the inhibition of Nipah virus transmission through targeting fusion glycoprotein and matrix proteinDeblina Rababi, Anish Nag. CANDC, 112:108135, 2024. [doi]

2023

in-silico pharmacophore-based molecular docking study to evaluate the inhibitory potentials of novel fungal triterpenoid Astrakurkurone analogues against a hypothetical mutated main protease of SARS-CoV-2 virusAnish Nag, Adhiraj Dasgupta, Sutirtha Sengupta, Tapan Kumar Lai, Krishnendu Acharya. cbm, 152:106433, 2023. [doi]

2022

in silico studyAnish Nag, Ritesh Banerjee, Subhabrata Paul, Rita Kundu. cbm, 146:105552, 2022. [doi]

2021

Network pharmacological evaluation for identifying novel drug-like molecules from ginger (Zingiber officinale Rosc.) against multiple disease targets, a computational biotechnology approachAnish Nag, Ritesh Banerjee. netmahib, 10(1):55, 2021. [doi]

In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking toolsAnish Nag, Subhabrata Paul, Ritesh Banerjee, Rita Kundu. cbm, 137:104818, 2021. [doi]

Sign in or sign up to see more results.

runs on WebDSL